文献速递生殖医学

癌症或造血干细胞移植后女性生育力保存的活产率:胚胎、卵母细胞和卵巢组织冷冻保存三种主要技术的系统综述与Meta分析

Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation.
PubMed 文献 · Hum Reprod · 2023-01-01

该系统综述与Meta分析纳入34项研究,评估癌症或造血干细胞移植后女性生育力保存的活产率。胚胎冷冻后体外受精活产率为41%,卵母细胞玻璃化冷冻后为32%,卵巢组织冷冻移植后体外受精活产率为21%,自发活产率为33%。

要点

  • 胚胎冷冻后体外受精活产率为41%(95%CI:34-48)。
  • 卵母细胞玻璃化冷冻后活产率为32%(95%CI:26-39)。
  • 卵巢组织冷冻移植后体外受精活产率为21%,自发活产率为33%。

核心结论

  • 胚胎和卵母细胞冷冻保存后的活产率分别为41%和32%,卵巢组织冷冻移植后体外受精和自发活产率分别为21%和33%。

研究设计与样本

  • 系统综述与Meta分析,检索2004年1月至2021年5月Medline、Embase和Cochrane Library,最终纳入34项研究。

主要发现

  • 胚胎冷冻后体外受精活产率为41%(95%CI:34-48,I²:0%,固定效应)。
  • 卵母细胞玻璃化冷冻后活产率为32%(95%CI:26-39,I²:0%,固定效应)。
  • 卵巢组织移植后体外受精活产率为21%(95%CI:15-26,I²:0%,固定效应),自发活产率为33%(95%CI:25-42,I²:46.1%,随机效应)。
  • 所有结局的敏感性分析中,估计百分比的最大变化为1%。

临床怎么用

  • 本Meta分析提供有限数据,可能有助于临床医生为患者提供咨询。

局限性

  • 文献异质性妨碍了对三种技术的比较。
  • 本Meta分析提供的数据有限,可能有助于临床医生为患者提供咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the chances of achieving a live birth after embryo, oocyte and ovarian tissue cryopreservation (OTC) in female cancer survivors? SUMMARY ANSWER: The live birth rates (LBRs) following embryo and oocyte cryopreservation are 41% and 32%, respectively, while for IVF and spontaneous LBR after tissue cryopreservation and transplantation, these rates are 21% and 33%, respectively. WHAT IS KNOWN ALREADY: Currently, fertility preservation (FP) has become a major public health issue as diagnostic and therapeutic progress has made it possible to achieve an 80% survival rate in children, adolescents and young adults with cancer. In the latest ESHRE guidelines, only oocyte and embryo cryopreservation are considered as established options for FP. OTC is still considered to be an innovative method, while it is an acceptable FP technique in the American Society for Reproductive Medicine guidelines. However, given the lack of studies on long-term outcomes after FP, it is still unclear which technique offers the best chance to achieve a live birth. STUDY DESIGN, SIZE, DURATION: We performed a systematic review and meta-analysis of published controlled studies. Searches were conducted from January 2004 to May 2021 in Medline, Embase and the Cochrane Library using the following search terms: cancer, stem cell transplantation, FP, embryo cryopreservation, oocyte vitrification, OTC and reproductive outcome. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 126 full-text articles were preselected from 1436 references based on the title and abstract and assessed via the Newcastle-Ottawa Quality Assessment Scale. The studies were selected, and their data were extracted by two independent reviewers according to the Cochrane methods. A fixed-effect meta-analysis was performed for outcomes with high heterogeneity. MAIN RESULTS AND THE ROLE OF CHANCE: Data from 34 studies were used for this meta-analysis. Regarding cryopreserved embryos, the LBR after IVF was 41% (95% CI: 34-48, I2: 0%, fixed effect). Concerning vitrified oocytes, the LBR was 32% (95% CI: 26-39, I2: 0%, fixed effect). Finally, the LBR after IVF and the spontaneous LBR after ovarian tissue transplantation were 21% (95% CI: 15-26, I2: 0%, fixed-effect) and 33% (95% CI: 25-42, I2: 46.1%, random-effect), respectively. For all outcomes, in the sensitivity analyses, the maximum variation in the estimated percentage was 1%. LIMITATIONS, REASONS FOR CAUTION: The heterogeneity of the literature prevents us from comparing these three techniques. This meta-analysis provides limited data which may help clinicians when counselling patients. WIDER IMPLICATIONS OF THE FINDINGS: This study highlights the need for long-term follow-up registries to assess return rates, as well as spontaneous pregnancy rates and birth rates after FP. STUDY FUNDING/COMPETING INTEREST(S): This work was sponsored by an unrestricted grant from GEDEON RICHTER France. The authors have no competing interests to declare. REGISTRATION NUMBER: CRD42021264042.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Fraison E, Huberlant S, Labrune E, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod. 2023. PMID: 36421038. doi:10.1093/humrep/deac249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。